The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA
NCT06112548
Summary
This interventional study aims to compare the effectiveness of local multimodal drug periarticular injection in TKA patients with the standard pain control regime that includes opioids, NSAIDs, and other analgesics. The main questions The investigators strive to answer are: Is there a significant difference in the severity of pain and functional outcomes when applying periarticular injections? Are there any increased complications when applying the periarticular injections?
Eligibility
Inclusion Criteria: * all patients with end-stage arthritis of the knee going primary unilateral total knee arthroplasty. Exclusion Criteria: * inflammatory and secondary arthritis of the knee. * Patients who are allergic to one or more of the drugs used in the injections. * Patients who are already taking opioids for whatever reason or have a history of addiction. * BMI less than 20 and more than 35. * patients with intra-operative complications that would affect the outcomes measurement. * Patients who are going through complex primary or revision TKA. * Pregnancy, renal or liver failure. * Patients who are classified as grade 3 or more according to ASA.
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06112548